| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |